Development of Traceable Rituximab-Modified PEO-Polyester Micelles by Postinsertion of PEG-phospholipids for Targeting of B-cell Lymphoma

[Image: see text] The objective of this work was to develop rituximab (RTX)-modified polymeric micelles for targeting of B-cell lymphoma cells, through postinsertion of RTX-poly(ethylene glycol)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine (RTX-PEG-DSPE) into methoxy poly(ethylene oxide)-poly(ε-c...

Full description

Saved in:
Bibliographic Details
Published in:ACS Omega
Main Authors: Saqr, Asma, Vakili, Mohammad Reza, Huang, Yung-Hsing, Lai, Raymond, Lavasanifar, Afsaneh
Format: Artigo
Language:Inglês
Published: American Chemical Society 2019
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6854837/
https://ncbi.nlm.nih.gov/pubmed/31737848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.9b02910
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items